Sjoerd H.
- Country
- The Netherlands
- Department
- Oncology
Research Overview
Data & Insights
Has run more than one trial at 34 of 70 partner sites.
Specializations
Breast Cancer Research
This investigator specializes in HER2-positive breast cancer treatment optimization, with particular focus on neoadjuvant chemotherapy approaches. Their research explores innovative image-guided treatment strategies and chemotherapy de-escalation protocols.
- HER2-targeted therapies
- Neoadjuvant treatment protocols
- Personalized therapy approaches
Additional expertise includes hormone receptor-positive breast cancer treatment optimization using endocrine therapy combinations.
Precision Oncology
The investigator focuses on targeted anti-cancer treatments based on genomic and protein expression profiles. Their work encompasses the evaluation of commercially available targeted therapies for various cancer types.
- Genomic-guided therapy selection
- Protein expression analysis
- Drug sensitivity prediction
Research interests include biomarker-driven treatment approaches across multiple cancer types.
Hematologic Oncology
The investigator conducts research in hematologic malignancies, particularly focusing on multiple myeloma and non-Hodgkin lymphoma. Their work involves evaluating novel therapeutic strategies for these conditions.
- Multiple myeloma treatments
- Lymphoma therapeutics
- Advanced solid tumors
Expertise extends to developing personalized treatment approaches for various blood cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.